2024 HCPCS Code J2281
Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg
TAGS: equivalent moxifloxacin therapeutically
Short Description | Inj moxifloxacin (fres kabi) |
HCPCS Coverage Code | C - Carrier judgment |
HCPCS Action Code | C - Change in long description of procedure or modifier code |
HCPCS Action Effective Date | July 01, 2024 |
HCPCS Code Added Date | January 01, 2023 |
HCPCS Pricing Indicator Code | 51 - Drugs |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Coverage Issues Manual Reference Section Number | |
HCPCS Type Of Service Code | 1 - Medical care |
HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- J0225 - Inj, vutrisiran, 1 mg
- J0248 - Inj, remdesivir, 1 mg
- J0256 - Alpha 1 proteinase inhibitor
- J0257 - Glassia injection
- J0270 - Alprostadil for injection
- J0275 - Alprostadil urethral suppos
- J0278 - Amikacin sulfate injection
- J0280 - Aminophyllin 250 mg inj
- J0282 - Amiodarone hcl
- J0283 - Inj, amiodarone (nexterone)
- J0285 - Amphotericin b
- J0287 - Amphotericin b lipid complex
- J0288 - Ampho b cholesteryl sulfate
- J0289 - Amphotericin b liposome inj
- J0290 - Ampicillin 500 mg inj
- J0291 - Inj., plazomicin, 5 mg
- J0295 - Ampicillin sulbactam 1.5 gm
- J0300 - Amobarbital 125 mg inj
- J0330 - Succinycholine chloride inj
- J0348 - Anidulafungin injection